Literature DB >> 34024159

SARS-CoV-2 variants: A double-edged sword?

Manasi P Jogalekar1, Anurag Veerabathini2, Prakash Gangadaran3,4.   

Abstract

Since the worldwide emergence of the COVID-19 outbreak, there have been international concerns about the possible viral evolution into variants with underlying mutations that may contribute to their increased transmissibility, disease severity, risk of death, and their potential escape from the immune response or may even lead to its extinction. Rigorous surveillance has revealed the variants harboring mutations in the spike protein, the main target of neutralizing antibodies generated through vaccination or herd immunity. In this review, we have highlighted major SARS-CoV-2 variants as well as other local strains along with their specific mutations, suspected changes in their characteristics, and their impact on the current pandemic and vaccine efficacy. We have also emphasized the need to develop widely protective interventions to curb further transmission of variants.

Entities:  

Keywords:  B.1.1.7; COVID-19; SARS-CoV-2; mutations; spike protein; variants

Mesh:

Substances:

Year:  2021        PMID: 34024159      PMCID: PMC8719041          DOI: 10.1177/15353702211014146

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  27 in total

1.  Genetic Variants of SARS-CoV-2-What Do They Mean?

Authors:  Adam S Lauring; Emma B Hodcroft
Journal:  JAMA       Date:  2021-02-09       Impact factor: 56.272

2.  Rare COVID reactions might hold key to variant-proof vaccines.

Authors:  Ewen Callaway
Journal:  Nature       Date:  2021-04       Impact factor: 49.962

3.  Fast-spreading U.K. virus variant raises alarms.

Authors:  Kai Kupferschmidt
Journal:  Science       Date:  2021-01-01       Impact factor: 47.728

4.  Spike mutation D614G alters SARS-CoV-2 fitness.

Authors:  Jessica A Plante; Yang Liu; Jianying Liu; Hongjie Xia; Bryan A Johnson; Kumari G Lokugamage; Xianwen Zhang; Antonio E Muruato; Jing Zou; Camila R Fontes-Garfias; Divya Mirchandani; Dionna Scharton; John P Bilello; Zhiqiang Ku; Zhiqiang An; Birte Kalveram; Alexander N Freiberg; Vineet D Menachery; Xuping Xie; Kenneth S Plante; Scott C Weaver; Pei-Yong Shi
Journal:  Nature       Date:  2020-10-26       Impact factor: 49.962

5.  We shouldn't worry when a virus mutates during disease outbreaks.

Authors:  Nathan D Grubaugh; Mary E Petrone; Edward C Holmes
Journal:  Nat Microbiol       Date:  2020-04       Impact factor: 17.745

6.  Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.

Authors:  Erik Volz; Verity Hill; John T McCrone; Anna Price; David Jorgensen; Áine O'Toole; Joel Southgate; Robert Johnson; Ben Jackson; Fabricia F Nascimento; Sara M Rey; Samuel M Nicholls; Rachel M Colquhoun; Ana da Silva Filipe; James Shepherd; David J Pascall; Rajiv Shah; Natasha Jesudason; Kathy Li; Ruth Jarrett; Nicole Pacchiarini; Matthew Bull; Lily Geidelberg; Igor Siveroni; Ian Goodfellow; Nicholas J Loman; Oliver G Pybus; David L Robertson; Emma C Thomson; Andrew Rambaut; Thomas R Connor
Journal:  Cell       Date:  2020-11-19       Impact factor: 41.582

7.  First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020.

Authors:  Simona Fiorentini; Serena Messali; Alberto Zani; Francesca Caccuri; Marta Giovanetti; Massimo Ciccozzi; Arnaldo Caruso
Journal:  Lancet Infect Dis       Date:  2021-01-12       Impact factor: 25.071

8.  Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies.

Authors:  Allison J Greaney; Andrea N Loes; Katharine H D Crawford; Tyler N Starr; Keara D Malone; Helen Y Chu; Jesse D Bloom
Journal:  Cell Host Microbe       Date:  2021-02-08       Impact factor: 21.023

9.  Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans.

Authors:  Bas B Oude Munnink; Reina S Sikkema; David F Nieuwenhuijse; Robert Jan Molenaar; Emmanuelle Munger; Richard Molenkamp; Arco van der Spek; Paulien Tolsma; Ariene Rietveld; Miranda Brouwer; Noortje Bouwmeester-Vincken; Frank Harders; Renate Hakze-van der Honing; Marjolein C A Wegdam-Blans; Ruth J Bouwstra; Corine GeurtsvanKessel; Annemiek A van der Eijk; Francisca C Velkers; Lidwien A M Smit; Arjan Stegeman; Wim H M van der Poel; Marion P G Koopmans
Journal:  Science       Date:  2020-11-10       Impact factor: 47.728

10.  Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.

Authors:  Bette Korber; Will M Fischer; Sandrasegaram Gnanakaran; Hyejin Yoon; James Theiler; Werner Abfalterer; Nick Hengartner; Elena E Giorgi; Tanmoy Bhattacharya; Brian Foley; Kathryn M Hastie; Matthew D Parker; David G Partridge; Cariad M Evans; Timothy M Freeman; Thushan I de Silva; Charlene McDanal; Lautaro G Perez; Haili Tang; Alex Moon-Walker; Sean P Whelan; Celia C LaBranche; Erica O Saphire; David C Montefiori
Journal:  Cell       Date:  2020-07-03       Impact factor: 66.850

View more
  12 in total

Review 1.  COVID-19 and diabetes: What do we know so far?

Authors:  Prakash Gangadaran; Himabindu Padinjarathil; Shri Hari Subhashri Rajendran; Manasi P Jogalekar; Chae Moon Hong; Baladhandapani Aruchamy; Uma Maheswari Rajendran; Sridharan Gurunagarajan; Anand Krishnan; Prasanna Ramani; Kavimani Subramanian
Journal:  Exp Biol Med (Maywood)       Date:  2022-07-27

2.  Convalescent serum-derived exosomes: Attractive niche as COVID-19 diagnostic tool and vehicle for mRNA delivery.

Authors:  Anand Krishnan; Prakash Gangadaran; Vivek P Chavda; Manasi P Jogalekar; Ramesh Muthusamy; Disha Valu; Chithravel Vadivalagan; Prasanna Ramani; Alexey Laishevtcev; Naresh Kumar Katari; Byeong-Cheol Ahn
Journal:  Exp Biol Med (Maywood)       Date:  2022-05-13

Review 3.  Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?

Authors:  Johnson M Liu; Jeffrey Chi
Journal:  Exp Biol Med (Maywood)       Date:  2022-01-22

4.  Nasopharyngeal and oropharyngeal rinses with neutral electrolyzed water prevents COVID-19 in front-line health professionals: A randomized, open-label, controlled trial in a general hospital in Mexico City.

Authors:  Rafael Gutiérrez-García; Juan C De La Cerda-Ángeles; Ariana Cabrera-Licona; Ivan Delgado-Enciso; Nicolas Mervitch-Sigal; Brenda A Paz-Michel
Journal:  Biomed Rep       Date:  2021-12-15

5.  Induction of Broadly Cross-Reactive Antibodies by Displaying Receptor Binding Domains of SARS-CoV-2 on Virus-like Particles.

Authors:  Xinyue Chang; Xuelan Liu; Mona O Mohsen; Andris Zeltins; Byron Martina; Monique Vogel; Martin F Bachmann
Journal:  Vaccines (Basel)       Date:  2022-02-16

Review 6.  Delta Variant: The New Challenge of COVID-19 Pandemic, an Overview of Epidemiological, Clinical, and Immune Characteristics.

Authors:  Noosha Samieefar; Ronak Rashedi; Meisam Akhlaghdoust; Melika Mashhadi; Pouya Darzi; Nima Rezaei
Journal:  Acta Biomed       Date:  2022-03-14

7.  Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2.

Authors:  Maik Friedrich; Gabriele Pfeifer; Stefanie Binder; Achim Aigner; Philippe Vollmer Barbosa; Gustavo R Makert; Jasmin Fertey; Sebastian Ulbert; Jochen Bodem; Eva-Maria König; Nina Geiger; Axel Schambach; Erik Schilling; Tilo Buschmann; Sunna Hauschildt; Ulrike Koehl; Katherina Sewald
Journal:  Front Bioeng Biotechnol       Date:  2022-03-02

8.  Both simulation and sequencing data reveal coinfections with multiple SARS-CoV-2 variants in the COVID-19 pandemic.

Authors:  Yinhu Li; Yiqi Jiang; Zhengtu Li; Yonghan Yu; Jiaxing Chen; Wenlong Jia; Yen Kaow Ng; Feng Ye; Shuai Cheng Li; Bairong Shen
Journal:  Comput Struct Biotechnol J       Date:  2022-03-18       Impact factor: 7.271

9.  Low Represented Mutation Clustering in SARS-CoV-2 B.1.1.7 Sublineage Group with Synonymous Mutations in the E Gene.

Authors:  Paolo Giuseppe Bonacci; Dalida Angela Bivona; Dafne Bongiorno; Stefano Stracquadanio; Mariacristina Massimino; Carmelo Bonomo; Alessia Stracuzzi; Paolo Pennisi; Nicolò Musso; Stefania Stefani
Journal:  Diagnostics (Basel)       Date:  2021-12-07

Review 10.  PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis.

Authors:  Willie Elliott; Maheedhara R Guda; Swapna Asuthkar; Narasaraju Teluguakula; Durbaka V R Prasad; Andrew J Tsung; Kiran K Velpula
Journal:  Biomedicines       Date:  2021-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.